Chemclin Diagnostics Co., Ltd. (SHA:688468)
China
· Delayed Price · Currency is CNY 7.20
-0.08 (-1.10%)
May 30, 2025, 3:00 PM CST
Chemclin Diagnostics Market Cap
Chemclin Diagnostics has a market cap or net worth of 2.84 billion as of June 2, 2025. Its market cap has decreased by -3.33% in one year.
Market Cap
2.84B
Enterprise Value
2.21B
Revenue
406.20M
Ranking
n/a
PE Ratio
27.34
Stock Price
7.20
Market Cap Chart
Since April 9, 2021, Chemclin Diagnostics's market cap has decreased from 10.00B to 2.84B, a decrease of -71.59%. That is a compound annual growth rate of -26.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 2.84B | 5.11% |
| Dec 31, 2024 | 2.70B | -37.53% |
| Dec 29, 2023 | 4.33B | 13.94% |
| Dec 30, 2022 | 3.80B | -47.15% |
| Dec 31, 2021 | 7.19B | -28.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 362.72B |
| Shenzhen Mindray Bio-Medical Electronics | 273.17B |
| WuXi AppTec | 181.57B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.11B |
| Sichuan Biokin Pharmaceutical | 120.77B |
| Aier Eye Hospital Group | 115.34B |
| Shanghai United Imaging Healthcare | 112.70B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |